Mykofungin 3 (Clotrimazole)

Clotrimazole, the active ingredient in Mykofungin 3, is an azole antifungal presented as a vaginal formulation for local use. It treats vaginal candidiasis by targeting fungal growth in the affected area.

GNH USA supplies Mykofungin 3 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mykofungin 3, a topical azole antifungal, is used to manage fungal infections of the vaginal mucosa.

Vulvovaginal candidiasis: reduces itching, discharge and irritation caused by Candida species. Recurrent vaginal yeast infection: helps prevent recurrence when used as prescribed. Topical antifungal therapy: provides local eradication of fungal over‑growth in the vaginal mucosa.

Local application of Mykofungin 3 may cause mild, transient reactions.

Common Side Effects: - Vaginal irritation or burning sensation. - Itching or mild discomfort. - Unpleasant vaginal discharge. - Local redness or swelling. - Mild odor change. - Slight spotting after insertion.

Serious or Rare Side Effects: - Allergic reaction with rash or hives. - Severe skin eruption such as Stevens‑Johnson syndrome. - Vulvar edema or swelling. - Systemic hypersensitivity reactions. - Rare hepatotoxicity with systemic absorption. - Persistent severe irritation requiring medical attention.

Before using Mykofungin 3, consider the following safety measures.

Assess for hypersensitivity: avoid if known allergy to clotrimazole or other azoles. Avoid use in severe hepatic impairment: limited systemic absorption but caution is advised. Pregnancy considerations: consult a healthcare professional before use during pregnancy. Limit duration of therapy: follow prescriber instructions to reduce resistance risk. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Clotrimazole may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Concurrent systemic azoles: may increase systemic exposure. - Use with oral contraceptives: may reduce efficacy. - Co‑administration with hepatotoxic drugs: monitor liver function.

Moderate Interactions (Monitor Closely): - Topical irritants: may increase local irritation. - Other vaginal products (douches, spermicides): may affect absorption. - Simultaneous use of multiple topical antifungals: risk of resistance.